[Results of the Collaborative Initial Glaucoma Treatment Study (CIGTS)]

Area of Science:

• Ophthalmology
• Clinical Trials
• Glaucoma Management

Background:

• Open-angle glaucoma is a leading cause of irreversible blindness worldwide.
• Accurate diagnosis and timely intervention are crucial for preserving vision.
• Initial treatment strategies include medical therapy and surgical interventions like trabeculectomy.

Purpose of the Study:

• To compare the efficacy of initial medical therapy versus trabeculectomy in treating newly diagnosed open-angle glaucoma.
• To assess the impact of both treatments on visual field progression, intraocular pressure, and visual acuity over five years.
• To evaluate patient quality of life and symptom reporting in response to initial treatment.

Main Methods:

• The Collaborative Initial Glaucoma Treatment Study (CIGTS) enrolled 607 patients with newly diagnosed open-angle glaucoma.
• Participants were randomized to receive either local medical therapy or trabeculectomy.
• Outcomes including intraocular pressure, visual fields, visual acuity, and quality of life were monitored over a 5-year period with 6-month follow-ups.

Main Results:

• Both treatment groups achieved significant reductions in intraocular pressure (IOP).
• Trabeculectomy demonstrated superior efficacy in lowering IOP compared to medical therapy.
• Quality of life assessments revealed minor differences; medically treated patients reported slightly more ocular symptoms.

Conclusions:

• Trabeculectomy is a more effective initial treatment for lowering intraocular pressure in open-angle glaucoma patients.
• While both treatments are effective, trabeculectomy may lead to fewer ocular symptoms in the long term.
• Further research may explore long-term visual field preservation and patient-reported outcomes for both strategies.